Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 20,717 shares, an increase of 67.5% from the July 30th total of 12,368 shares. Based on an average daily volume of 4,199 shares, the short-interest ratio is presently 4.9 days.

Cardio Diagnostics Stock Down 3.0%

Shares of CDIOW stock opened at $0.02 on Wednesday. Cardio Diagnostics has a 1-year low of $0.01 and a 1-year high of $0.07. The business’s fifty day moving average price is $0.02 and its 200 day moving average price is $0.02.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.